Search

Pages

1. • Journal article

   • 

   Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply

   Jacobs, Bart[UCL] Piessevaux, Hubert[UCL] De Roock, Wendy[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Claes, Bart[UCL] Tejpar, Sabine[UCL] (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. E175-E176 (2010)
2. • Journal article

   • 

   Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

   Debucquoy, Annelies Haustermans, Karin Daemen, Anneleen Aydin, Selda[UCL] Libbrecht, Louis Gevaert, Olivier De Moor, Bart Tejpar, Sabine McBride, William H Penninckx, Freddy Scalliet, Pierre[UCL] Stroh, Christopher Vlassak, Soetkin Sempoux, Christine[UCL] Machiels, Jean-Pascal[UCL] (2009) Journal of Clinical Oncology — Vol. 27, no. 17, p. 2751-2757 (2009)
3. • Journal article

   • 

   Zeb2 drives invasive and microbiota-dependent colon carcinoma

   Slowicka, Karolina Petta, Ioanna Blancke, Gillian Hoste, Esther Dumas, Emilie Sze, Mozes Vikkula, Hanna Radaelli, Enrico Haigh, Jody J. Jonckheere, Sven Taminau, Joachim Vandamme, Niels Wullaert, Andy Tulchinsky, Eugene Nittner, David Van Vlierberghe, Pieter De Hertogh, Gert Baldin, Pamela[UCL] Etlioglu, Emre Wirapati, Pratyaksha Boon, Louis Lambrecht, Bart N. Callewaert, Chris Tejpar, Sabine Goossens, Steven Berx, Geert Vereecke, Lars van Loo, Geert (2020) Nature Cancer — Vol. 1, no.6, p. 620-634 (2020)
4. • Speech

   • 

   Dose-escalation study using up to twice the standard dose of cetuximab in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST study): Preliminary data.

   Tejpar, Sabine[UCL] Humblet, Yves[UCL] Peeters, Marie-Rose[UCL] Gelderblom, H. Vermorken, J. Viret, F. Glimelius, B. Ciardiello, F. Kisker, O. Van Cutsem, Emmanuel[UCL] (2006) 42nd Annual Meeting of the American-Society-of-Clinical-Oncology — Atlanta (Ga)
5. • Speech

   • 

   DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease

   De Roock, Wendy Janssens, Marc Biesmans, Bart Jacobs, Bart De Schutter, Jef Humblet, Yves[UCL] Peeters, Marc Van Cutsem, Eric Marynen, Peter Tejpar, Sabine (2008) 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics — (Switzerland) Geneva
6. • Journal article

   • 

   Multiomics and spatial mapping characterizes human CD8 ⁺ T cell states in cancer

   Naulaerts, Stefan Datsi, Angeliki Borras, Daniel M. Antoranz Martinez, Asier Messiaen, Julie Vanmeerbeek, Isaure Sprooten, Jenny Laureano, Raquel S. Govaerts, Jannes Panovska, Dena Derweduwe, Marleen Sabel, Michael C. Rapp, Marion Ni, Weiming Mackay, Sean Van Herck, Yannick Gelens, Lendert Venken, Tom More, Sanket Bechter, Oliver Bergers, Gabriele Liston, Adrian De Vleeschouwer, Steven Van den Eynde, Benoit[UCL] Lambrechts, Diether Verfaillie, Michiel Bosisio, Francesca Tejpar, Sabine Borst, Jannie Sorg, Rüdiger V. De Smet, Frederik Garg, Abhishek D. (2023) Science Translational Medicine — Vol. 15, no.691 (2023)
7. • Journal article

   • 

   Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinoma.

   Slowicka, Karolina Petta, Ioanna Blancke, Gillian Hoste, Esther Dumas, Emilie Sze, Mozes Vikkula, Hanna Radaelli, Enrico Haigh, Jody J Jonckheere, Sven Taminau, Joachim Vandamme, Niels Wullaert, Andy Tulchinsky, Eugene Nittner, David Van Vlierberghe, Pieter De Hertogh, Gert Baldin, Pamela[UCL] Etlioglu, Emre Wirapati, Pratyaksha Boon, Louis Lambrecht, Bart N Callewaert, Chris Tejpar, Sabine Goossens, Steven Berx, Geert Vereecke, Lars van Loo, Geert (2020) Nature cancer — Vol. 1, no.7, p. 750 (2020)
8. • Journal article

   • 

   Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study

   Van Cutsem, Eric Tejpar, Sabine Vanbeckevoort, Dirk Peeters, Marc Humblet, Yves[UCL] Gelderblom, Hans Vermorken, Jan B Viret, Frederic Glimelius, Bengt Gallerani, Elisa Hendlisz, Alain Cats, Annemieke Moehler, Markus Sagaert, Xavier Vlassak, Soetkin Schlichting, Michael Ciardiello, Fortunato (2012) Journal of Clinical Oncology — Vol. 30, no.23, p. 2861-2868 (2012)
9. • Journal article

   • 

   Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer

   Cappellesso, Federica Orban, Marie-Pauline Shirgaonkar, Niranjan Berardi, Emanuele Serneels, Jens Neveu, Marie-Aline di Molfetta, Daria Piccapane, Francesca Caroppo, Rosa Debellis, Lucantonio Ostyn, Tessa Joudiou, Nicolas[UCL] Mignion, Lionel[UCL] Richiardone, Elena[UCL] Jordan, Bénédicte[UCL] Gallez, Bernard[UCL] Corbet, Cyril[UCL] Roskams, Tania Dasgupta, Ramanuj Tejpar, Sabine Di Matteo, Mario Taverna, Daniela Reshkin, Stephan Joel Topal, Baki Virga, Federico Mazzone, Massimiliano (2022) Nature Cancer — Vol. 3, p. 1464-1483 (2022)
10. • Speech

    • 

    Levels of amphiregulin and epiregulin expression correlate with overall survival in colorectal cancer treated with cetuximab

    De Roock, Wendy[UCL] Piessevaux, Hubert[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Van Cutsem, Emmanuel[UCL] Tejpar, Sabine[UCL] (2007) Annual Meeting of the EORTC-NCI-ASCO on Molecular Markers in Cancer — Brussels (Belgium)
11. • Speech

    • 

    Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition

    Jacobs, Bart Van Oirbeek, Robin Biesmans, Bart Fieuws, Steffen De Roock, Wendy De Schutter, Jef Humblet, Yves[UCL] Peeters, Marc Van Cutsem, Eric Tejpar, Sabine (2008) 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics — (Switzerland) Geneva
12. • Speech

    • 

    High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease

    Tejpar, Sabine[UCL] Piessevaux, Hubert[UCL] Humblet, Yves[UCL] De Roock, Wendy[UCL] Biesemans, Bart[UCL] De Schutter, Jef[UCL] Peeters, Marc Celik, Ilhan Van Cutsem, Eric[UCL] (2007) —
13. • Speech

    • 

    Intrinsic Resistance To the Antiproliferative Effects of Azd6244 a Selective Mek1/2 Inhibitor Is Associated With Concomitant K-ras and Pi3kca Gene Mutations in Colorectal Cancer Cells

    Troiani, T. Vecchione, I. Capasso, A. Martinelli, E. Caraglia, M. Marra, M. De Roock, Wendy[UCL] Tejpar, Sabine[UCL] Van Cutsem, E.[UCL] Ciardiello, F. (2010) 12th World Congress on Gastrointestinal Cancer — Barcelona(Spain)
14. • Journal article

    • 

    Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

    Dercle, Laurent Lu, Lin Schwartz, Lawrence H Qian, Min Tejpar, Sabine Eggleton, Peter Zhao, Binsheng Piessevaux, Hubert[UCL] (2020) Journal of the National Cancer Institute — Vol. 112, no.9, p. 902-912 (2020)
15. • Journal article

    • 

    Molecular test algorithms for digestive tumours

    Hébrant, Aline Mourin, Anne[UCL] Froyen, Guy Van der Meulen, Joni de Man, Marc Salgado, Roberto Van den Eynde, Marc[UCL] D'haene, Nicky Martens, Geert Van Cutsem, Eric Antoine-Poirel, Hélène[UCL] Tejpar, Sabine Van Laethem, Jean-Luc Geboes, Karen Pauwels, Patrick Dedeurwaerdere, Francesca Maes, Brigitte De Greve, Jacques Vanhuysse, Jacques Peeters, Pascal Vanacker, Leen Gomez-Galdon, Maria Chintinne, Marie Hendlisz, Alain De Hertogh, Gert Sagaert, Xavier Peeters, Marc Vannuffel, Pascal Lefesvre, Pierre Vermeij, Joanna Simoens, Marc Van den Moorter, Tom Van Damme, Nancy Van den Bulcke Marc (2019) Belgian Journal of Medical Oncology — Vol. 13, no.1, p. 4-10 (2019)
16. • Journal article

    • 

    Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial

    Tejpar, Sabine Yan, Pu Piessevaux, Hubert[UCL] Dietrich, Daniel Brauchli, Peter Klingbiel, Dirk Fiocca, Roberto Delorenzi, Mauro Bosman, Fred Roth, Arnaud D. (2018) European Journal of Cancer — Vol. 99, p. 66-77 (2018)
17. • Journal article

    • 

    FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: An international consortium study

    Geva, Ravit Vecchione, Loredana Kalogeras, Konstantinos T. Jensen, Benny Vittrup Lenz, Heinz-Josef Yoshino, Takayuki Paez, David Montagut, Clara Souglakos, John Cappuzzo, Federico Cervantes, Andrés Frattini, Milo Fountzilas, George Johansen, Julia S. Høgdall, Estrid Vilma Zhang, Wu Yang, Dongyun Yamazaki, Kentaro Nishina, Tomohiro Papamichael, Demetris Vincenzi, Bruno Macarulla, Teresa Loupakis, Fotios De Schutter, Jef Spindler, Karen Lise Garm Pfeiffer, Per Ciardiello, Fortunato Piessevaux, Hubert[UCL] Tejpar, Sabine (2015) Gut — Vol. 64, no. 6, p. 921-928 (2015)
18. • Journal article

    • 

    A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy

    Saridaki, Zenia Weidhaas, Joanne B. Lenz, Heinz-Josef Laurent-Puig, Pierre Jacobs, Bart De Schutter, Jef De Roock, Wendy Salzman, David W. Zhang, Wu Yang, Dongyun Pilati, Camilla Bouché, Olivier Piessevaux, Hubert[UCL] Tejpar, Sabine (2014) Clinical Cancer Research — Vol. 20, no. 17, p. 4499-4510 (2014)
19. • Journal article

    • 

    Reply to C. Cremolini et al

    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Biesmans, Bart De Schutter, Jef Claes, Bart Tejpar, Sabine (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. e175-e176 (2010)
20. • Journal article

    • 

    Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab.

    Piessevaux, Hubert[UCL] Buyse, Marc Schlichting, Michael Van Cutsem, Eric Bokemeyer, Carsten Heeger, Steffen Tejpar, Sabine (2013) Journal of Clinical Oncology — Vol. 31, no.30, p. 3764-3775 (2013)
21. • Journal article

    • 

    Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer.

    Geva, Ravit Vecchione, Loredana Tejpar, Sabine Piessevaux, Hubert[UCL] Van Cutsem, Eric Prenen, Hans (2013) OncoTargets and Therapy — Vol. 6, p. 53-58 (2013)
22. • Journal article

    • 

    Personalized medicine in metastatic colorectal cancer treated with anti-epidermal growth factor receptor agents: A future opportunity?

    Tejpar, Sabine Piessevaux, Hubert[UCL] (2014) Asia Pacific Journal of Clinical Oncology — Vol. 10, no. SUPPL.1, p. 2-10 (2014)
23. • Journal article

    • 

    Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab

    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Van Oirbeek, Robin Biesmans, Bart De Schutter, Jef Fieuws, Steffen Vandesompele, Jo Peeters, Marc Van Laethem, Jean-Luc Humblet, Yves[UCL] Pénault-Llorca, Frédérique De Hertogh, Gert Laurent-Puig, Pierre Van Cutsem, Eric Tejpar, Sabine (2009) Journal of Clinical Oncology — Vol. 27, no. 30, p. 5068-5074 (2009)
24. • Journal article

    • 

    KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

    De Roock, Wendy Piessevaux, Hubert[UCL] De Schutter, Jef Janssens, Marc De Hertogh, Gert Personeni, Nicola Biesmans, Bart Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Annals of Oncology — Vol. 19, no. 3, p. 508-515 (2008)
25. • Journal article

    • 

    Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study

    Tejpar, Sabine Piessevaux, Hubert[UCL] Claes, Kathleen Piront, Patricia Hoenderop, Joost G. J. Verslype, Chris Van Cutsem, Eric[UCL] (2007) The Lancet Oncology — Vol. 8, no. 5, p. 387-394 (2007)

Pages